DOI: https://doi.org/10.14710/dmj.v14i1.47014

The Relationship between Chemotherapy Treatment and the Incidence of Seborrheic Dermatitis in Cancer Patients at Dr. Kariadi Hospital

Dhiya Nasywa Ananda Giany  -  Department of Medicine, Universitas Diponegoro, Jl. Prof. Sudarto, SH, Tembalang, Semarang, Indonesia 50275, Indonesia
*Liza Afriliana scopus  -  Department of Dermatology and Venereology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia 50275, Indonesia
Widyawati Widyawati  -  Department of Dermatology and Venereology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia 50275, Indonesia
Buwono Puruhito scopus  -  Department of Dermatology and Venereology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia 50275, Indonesia

Citation Format:
Abstract

Background: Seborrheic dermatitis is a chronic inflammation of sebaceous gland-rich areas in the form of reddish, well-demarcated plaques and yellowish flaking scabs that can interfere with the patient's comfort and quality of life. Immune system suppression such as chemotherapy in cancer patients is thought to be one of the contributing factors. When seborrheic dermatitis is caused by chemotherapy, it will add to the suffering of patients both in terms of quality of life and treatment costs. Objective: To find out the difference in the incidence of seborrheic dermatitis in cancer patients who are undergoing chemotherapy and cancer patients who are not receiving chemotherapy. Methods: This study was an analytic observational study with a cross-sectional design. The study subjects were 40 people who were cancer patients at Dr. Kariadi Hospital who were selected by consecutive sampling method. The questionnaire used to determine the details of chemotherapy actions and the incidence of seborrheic dermatitis made by the author has been tested validity. Data processing used Chi Square or Fisher Exact analysis test and multivariate logistic regression test. Results: There was 73.3% incidence of seborrheic dermatitis in patients who were undergoing chemotherapy, 26.7% incidence of seborrheic dermatitis in patients who were not. The Chi Square test found a significant association between chemotherapy treatment and the incidence of seborrheic dermatitis with p = 0.022. The bivariate analysis test did not show a significant relationship between age, gender, and personal hygiene with the incidence of seborrheic dermatitis. There was a significant and additive relationship between chemotherapy treatment and personal hygiene with the incidence of seborrheic dermatitis. Conclusion: Chemotherapy treatment is a risk factor for Seborrheic Dermatitis. Age, gender and personal hygiene are not independent risk factors for seborrheic dermatitis. Poor personal hygiene is also a risk factor when combined with chemotherapy.

Keywords: Age, Chemotherapy, Gender, Personal hygiene, Seborrheic dermatitis
Fulltext View|Download
Keywords: Age; Chemotherapy; Gender; Personal hygiene; Seborrheic dermatitis

Article Metrics:

Article Info
Section: Original Articles
Language : EN
Recent articles
Quality of Life of Geriatrics Patient Suffering from Hypertension with Diabetes Mellitus Comorbid and Factors that Influence It Maternal and Perinatal Outcomes of Early and Late Onset Preeclampsia with Severe Features in Secondary Health Care The Relationship between Chemotherapy Treatment and the Incidence of Seborrheic Dermatitis in Cancer Patients at Dr. Kariadi Hospital More recent articles
  1. Tucker D, Masood S. Seborrheic Dermatitis. [Updated 2023]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551707/
  2. Xuan M., Lu C. & He Z. Clinical characteristics and quality of life in seborrheic dermatitis patients: a cross-sectional study in China. Health Qual Life Outcomes. 2020; 18:308. https://doi.org/10.1186/s12955-020-01558-y
  3. Sampogna F, Linder D, Piaserico S, Altomare G, Bortune M, Calzavara-Pinton P, et al. Penilaian kualitas hidup pasien dengan dermatitis kulit kepala menggunakan versi Italia dari kulit kepala. Acta Derm Venereol. 2014; 94(4):411-4
  4. Kusuma RB, Budiastuti A, Widodo A. Beberapa Faktor Resiko Terjadinya Dermatitis Seboroik pada Karyawan Go-jek Kota Semarang. 2019; 8(1):458–67
  5. Borda LJ, Wikramanayake TC. Seborrheic Dermatitis and Dandruff: A Comprehensive Review. J Clin Investig Dermatol. 2015; 3(2): 10.13188/2373-1044.1000019. doi: 10.13188/2373-1044.1000019
  6. Thaha A. Hubungan Kepadatan Spesien Malassezia dan Keparahan Klinis Dermatitis Seboroik di Kepala. Jurnal Kedokteran dan Kesehatan. 2015; 2(2):124-129
  7. Adalsteinsson JA, Kaushik S, Muzumdar S, Guttman-Yassky E, Ungar J. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol. 2020; 29:481–489. https://doi.org/10.1111/exd.14091
  8. Pedrosa AF, Lisboa C, Rodrigues AG, J. Am. Acad. Dermatol. 2014; 71(1):170
  9. Prohic A, Sadikovic TJ, Krupalija-Fazlic M, S. Kuskunovic-Vlahovljak, Int. J. Dermatol. 2016; 55:494
  10. Gatot D. Infeksi Jamur Sistemik pada Pasien Immunocompromised. Sari Pediatri. 2016; (3):242. 10.14238/sp3.4.2002.242-6
  11. Kaul S, Kaffenberger BH, Choi JN, Kwatra SG. Cutaneous adverse reactions of anticancer agents. Dermatol Clin 2019; 37:555-568
  12. Shi VJ, Levy LL, Choi JN. Cutaneous manifestations of nontargeted and targeted chemotherapies. Semin Oncol 2016; 43:419-425
  13. Gönülal M, Keser M, Öztürk A. Investigating Dermatologic Side Effects of Anti-Cancer Chemotherapeutic Agents. J Turk Acad Dermatol 2020;14(4):102-106
  14. Teoh F, Pavelka N. How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions. Pathogens 2016; 5:6. doi: 10.3390/pathogens5010006
  15. Wikramanayake TC, Borda LJ, Miteva M, Paus R, Exper. Dermatol. 2019; 28:991
  16. Simbolon OM, Sulo HR. Hubungan Pemberian Kemoterapi pada Pasien Kanker dengan Kejadian Infeksi Covid-19. MEDFARM: Jurnal Farmasi dan Kesehatan, 2022;11(2):174-184
  17. Lim HW, Collins SAB, Resneck JS Jr, et al. The burden of skin disease in the United States. J Am Acad Dermatol. 2017; 76(5):958-972.e2. doi: 10.1016/j.jaad.2016.12.043
  18. Sanders MGH, Pardo LM, Franco OH, Ginger RS, Nijsten T. Prevalence and determinants of seborrhoeic dermatitis in a middle-aged and elderly population: the Rotterdam Study. British Journal of Dermatology. 2018;178(1):148–53
  19. Farage MA, Miller KW, Berardesca E et al. Clinical implications of aging skin: cutaneous disorders in the elderly. Am J Clin Dermatol 2009;10:73–86
  20. Schwartz JR, Messenger AG, Tosti A, Todd G, Hordinsky M, Hay RJ, Wang X, Zachariae C, Kerr KM, Henry JP, Rust RC, Robinson MK. A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health. Acta Derm Venereol. 2013; 93(2):131-7
  21. Sanders MGH, Pardo LM, Franco OH, Ginger RS, Nijsten T. Prevalensi dan determinan dermatitis seboroik pada populasi paruh baya dan lanjut usia: Studi Rotterdam. Br J Dermatol. 2018; 178(1):148-153
  22. Elewski BE. Safe and effective treatment of seborrheic dermatitis. Cutis. 2009;83:333–338
  23. Bolognia JL, Jorizzo JL, Rapini RP, et al. Dermatology. 2nd ed. Spain: Elsevier; 2008
  24. Ilmiah Kesehatan Sandi Husada J, Penelitian Hubungan Antara Jenis Kelamin Dengan Angka Kejadian Dermatitis Seboroik A, Silvia E, Effendi A, Nurfaridza I, Abdul Moeloek Lampung H. The Correlation between Gender and Incidence Rate off Seborrheic Dermatitis. Juni [Internet]. 2020;9(1):37–46. Available from: https://akper-sandikarsa.e-journal.id/JIKSH
  25. Sampaio, A.L.S.B., Mameri, Â.C.A., de Sousa Vargas, T.J., Ramos-e-Silva, M., Nunes, A.P. and da Silva Carneiro, S.C. Continued Medical Education. An Bras Dermatol. 2011;86(6):1061-74
  26. Park, S. Y., Kwon, H. H., Min, S., Yoon, J. Y., & Suh, D. H. Clinical manifestation and associated factors of seborrheic dermatitis in Korea. European Journal of Dermatology. 2016;26(2):173-176
  27. Aditya KG, Bluhm R, Cooper EA, et al. Seborrheic dermatitis. Dermatol Clin. 2003;21:401–412
  28. Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol 2013;31:343–51
  29. Rosner W, Auchus RJ, Azziz R et al. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92:405–13
  30. Chen W, Mempel M, Traidl-Hofmann C et al. Gender aspects in skin diseases. J Eur Acad Dermatol Venereol 2010;24:1378–85
  31. Putri A, Natalia D, Fitriangga A. The Relationship of Personal Hygiene with The Incidence Of Pityriasis Capitis Among Female Student Of Vocational and Pre-Professional High School 1 Mempawah Hilir. Jurnal Nasional Ilmu Kesehatan (JNIK) LP2M Unhas. 2020; 2(3):122-123
  32. Podewils LJ, Holtz T. Riekstina, Skripconoka Zarovska E, Kirvelaite G et al. Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patienls. Epidemiol infect. 2011;139(1):3-20
  33. Poindexter GB, Burkhart CN, Morrell DS. Therapies for pediatric seborrheic dermatitis. PediatrAnn. 2009;38(6):333–338

Last update:

No citation recorded.

Last update:

No citation recorded.